ZA822346B - Substituted imidazole and imidazoline derivatives and their preparation and use - Google Patents

Substituted imidazole and imidazoline derivatives and their preparation and use

Info

Publication number
ZA822346B
ZA822346B ZA822346A ZA822346A ZA822346B ZA 822346 B ZA822346 B ZA 822346B ZA 822346 A ZA822346 A ZA 822346A ZA 822346 A ZA822346 A ZA 822346A ZA 822346 B ZA822346 B ZA 822346B
Authority
ZA
South Africa
Prior art keywords
preparation
substituted imidazole
imidazoline derivatives
imidazoline
derivatives
Prior art date
Application number
ZA822346A
Other languages
English (en)
Inventor
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of ZA822346B publication Critical patent/ZA822346B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA822346A 1981-04-22 1982-04-05 Substituted imidazole and imidazoline derivatives and their preparation and use ZA822346B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8112506A GB2096987B (en) 1981-04-22 1981-04-22 Substituted imidazole and imidazole derivatives and their preparation and use

Publications (1)

Publication Number Publication Date
ZA822346B true ZA822346B (en) 1983-03-30

Family

ID=10521291

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA822346A ZA822346B (en) 1981-04-22 1982-04-05 Substituted imidazole and imidazoline derivatives and their preparation and use

Country Status (10)

Country Link
EP (1) EP0064820A1 (xx)
JP (1) JPS57181063A (xx)
AU (1) AU8223082A (xx)
CA (1) CA1183544A (xx)
DD (1) DD207375A1 (xx)
DK (1) DK174782A (xx)
FI (1) FI821316L (xx)
GB (1) GB2096987B (xx)
NO (1) NO821288L (xx)
ZA (1) ZA822346B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4992459A (en) * 1983-04-12 1991-02-12 Smithkline Beecham Corporation Dopamine-β-hydroxylase inhibitors
DE3428342A1 (de) * 1984-08-01 1986-02-13 Boehringer Ingelheim Vetmedica GmbH, 6507 Ingelheim Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4719223A (en) * 1985-10-31 1988-01-12 Smithkline Beckman Corporation Imidazolethiol dopamine-beta-hydroxylase inhibitors
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
US4876266A (en) * 1987-12-31 1989-10-24 Smithkline Beckman Corporation 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors
DE68917897D1 (de) * 1988-12-15 1994-10-06 Texaco Development Corp Verfahren zur Herstellung von Imidazolen.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050520A (en) * 1960-03-31 1962-08-21 Air Prod & Chem Process of preparing 2-olefinic imidazoles
US3502661A (en) * 1967-02-14 1970-03-24 Pfizer & Co C Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
IL39413A0 (en) * 1971-05-13 1972-07-26 Sparamedica Ag Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
SE7605958L (sv) * 1975-05-30 1976-12-01 Scherico Ltd Nya 2-imidazoliner och deras anvendning sasom hypoglykemiska medel

Also Published As

Publication number Publication date
DK174782A (da) 1982-10-23
CA1183544A (en) 1985-03-05
GB2096987A (en) 1982-10-27
FI821316A0 (fi) 1982-04-15
AU8223082A (en) 1982-10-28
JPS57181063A (en) 1982-11-08
NO821288L (no) 1982-10-25
FI821316L (fi) 1982-10-23
DD207375A1 (de) 1984-02-29
GB2096987B (en) 1984-04-04
EP0064820A1 (en) 1982-11-17

Similar Documents

Publication Publication Date Title
GB2115408B (en) Triazole and imidazole derivatives
EP0080442A3 (en) Di-galactose derivatives and their preparation
DE3471308D1 (en) Imidazoline derivatives, their preparation and therapeutical use
ZA822346B (en) Substituted imidazole and imidazoline derivatives and their preparation and use
ZA822780B (en) Imidazoline derivatives
DE3275377D1 (en) Fungicidal alkinyl-azole derivatives and their use
GB2092139B (en) Imidazoline derivatives
ZA8261B (en) Pyridinyl-substituted-benz imidazole derivatives and preparation
IL65353A0 (en) Imidazole derivatives,their preparation and their use as microbicides
GB2095251B (en) Imidazole derivatives
DE3272262D1 (en) Imidazole derivatives
ZA852765B (en) Imidazole derivatives
GB8500296D0 (en) Imidazole derivatives
GB8513246D0 (en) Imidazole derivatives
IL65389A0 (en) Substituted imidazole and imidazoline derivatives and their preparation and use
GB8513031D0 (en) Preparation of imidazoline derivatives
GB8321772D0 (en) Imidazole derivatives and salts
GB2102422B (en) Imidazoline derivatives
ZA84952B (en) Imidazole derivatives
ZA82357B (en) Imidazoline derivatives
IE820724L (en) Substituted imidazole and imidazoline derivatives
ZA813646B (en) Imidazole derivatives and preparation thereof
IE833072L (en) Imidazolines and imidazole derivatives
ZW24782A1 (en) Bicyclic imidazole or imidazoline derivatives
IE812093L (en) Imidazole derivatives